Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemoembolization, Therapeutic”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04472767
What this trial is testing

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHCC
University of California, Irvine 35
Not applicableNot Yet RecruitingNCT07480382
What this trial is testing

Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC

Who this might be right for
Initially Unresectable Hepatocellular Carcinoma
Hong Wu 30
Not applicableNot Yet RecruitingNCT06823050
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 59
Not applicableLooking for participantsNCT06876753
What this trial is testing

Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Zhongda Hospital 300
Not applicableWithdrawnNCT02304445
What this trial is testing

Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
Juan Sanabria, MD
Testing effectiveness (Phase 2)Study completedNCT00877071
What this trial is testing

LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed

Who this might be right for
Hepatocellular Carcinoma
University of Pittsburgh 2
Large-scale testing (Phase 3)UnknownNCT02338297
What this trial is testing

Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC

Who this might be right for
Carcinoma, Hepatocellular
Nanjing Medical University 236
Testing effectiveness (Phase 2)UnknownNCT04992143
What this trial is testing

TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC

Who this might be right for
BCLC Stage C Hepatocellular Carcinoma
First Affiliated Hospital of Zhejiang University 20
Testing effectiveness (Phase 2)UnknownNCT05576909
What this trial is testing

Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation

Who this might be right for
Hepatocellular Carcinoma
Beijing Tsinghua Chang Gung Hospital 20
Not applicableLooking for participantsNCT07408804
What this trial is testing

Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)
Bangladesh Medical University 40
Not applicableUnknownNCT04523467
What this trial is testing

Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 320
Large-scale testing (Phase 3)Study completedNCT00493402
What this trial is testing

Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 365
Large-scale testing (Phase 3)Study completedNCT00109954
What this trial is testing

Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Pittsburgh 120
Not applicableStudy completedNCT00815620
What this trial is testing

Best Therapy for Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Zentralklinik Bad Berka 150
Post-approval studies (Phase 4)UnknownNCT02631499
What this trial is testing

Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

Who this might be right for
Carcinoma, HepatocellularNeoplastic Cells, Circulating
Fudan University 256
Not applicableUnknownNCT04967482
What this trial is testing

DEB-TACE vs. cTACE as Conversion Therapy for Unresectable Large HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 216
Large-scale testing (Phase 3)Active Not RecruitingNCT03778957
What this trial is testing

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 724
Post-approval studies (Phase 4)UnknownNCT00556803
What this trial is testing

TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 120
Testing effectiveness (Phase 2)UnknownNCT05903456
What this trial is testing

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07738367
What this trial is testing

Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer(NSCLC)
Fujian Cancer Hospital 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation